Sanofi offers refunds for Cablivi in novel model for rebates
Pharmaceutical Technology
JANUARY 27, 2023
The program follows the lead of Pfizer’s warranty programs for Panzyga (immune globulin intravenous) and Xalkori (crizotinib), as pharma continues to explore new types of risk sharing agreements. In 2022, the number of risk sharing agreements peaked with 144 agreements being made in the pharmaceutical industry.
52 
Let's personalize your content